Everything Lupus: Resource Hub
COVID-19: PROOF OF VACCINATION
Read
One Catalyst Award for a total of $40,000 CDN to fund one project for a term of one year (Current year)
Read
Non-pharmacological interventions to improve the socioeconomic lives of individuals with SLE
Read
Immune and inflammatory mechanisms critical to the development of SLE, with a focus on RIPK3-dependent pathways
Read
COVID-19: PROOF OF VACCINATION
Read
Phenotyping SLE based on disease course: remitting-relapsing, persistently active and monophasic
Read
NATIONAL ADVISORY COMMITTEE OF IMMUNIZATION (NACI) RAPID RESPONSE: ADDITIONAL DOSE OF COVID-19 VACCINE IN IMMUNOCOMPROMISED INDIVIDUALS FOLLOWING 1- OR 2- DOSE PRIMARY SERIES
Read
If you’re moderately to severely immunocompromised due to disease or treatment,
Read
Canadian Lupus Registry
Read
Ontario individuals who are immunocompromised can get a fourth dose
Read
Government of Canada signs new COVID-19 antibody therapy agreement
Read
Canadian Rheumatology Association Position Statement on COVID-19 Vaccination
Read
